Universal Ibogaine provides update on status of current Cease Trade Order

2025-03-03T10:39:31-08:00February 5th, 2025|Universal Ibogaine News|

Calgary, AB – February 5, 2025 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, provides the following update related to the previously issued Management Cease Trade Order (“MCTO”). As was noted in the Company’s prior news releases (last dated January 27, 2025), UI was not in [...]

Universal Ibogaine provides Bi-weekly Default Status Report on year-end filings

2025-03-03T10:40:25-08:00January 27th, 2025|Universal Ibogaine News|

Calgary, AB – January 27, 2025 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, provides the following bi-weekly default status report update: Management Cease Trade Order (“MCTO”) Further to the Company’s prior news releases (dated November 18, November 26, December 11, and December 27, 2024 and [...]

Universal Ibogaine announces closing of sale of Belize property

2025-03-03T10:35:32-08:00January 22nd, 2025|Universal Ibogaine News|

Calgary, AB – January 22, 2025 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, is pleased to advise it has closed the sale of its Belize Property. As previously announced (see prior News Releases dated November 26, December 11, and December 27, 2024 and January 13, [...]

Universal Ibogaine provides Bi-weekly Default Status Report on year-end filings and update on Belize property sal

2025-03-03T10:28:26-08:00January 13th, 2025|Universal Ibogaine News|

Calgary, AB – January 13, 2025 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, provides the following bi-weekly default status report update: Management Cease Trade Order (“MCTO”) Further to the Company’s prior news releases (dated November 18, November 26, December 11 and December 27, 2024), the [...]

Universal Ibogaine provides Bi-weekly Default Status Report on year-end filings and update on Belize property sale

2025-03-03T10:20:02-08:00December 27th, 2024|Universal Ibogaine News|

Calgary, AB – December 27, 2024 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, provides the following bi-weekly default status report update. Management Cease Trade Order (“MCTO”) Further to the Company’s prior news releases (November 18, 26 and December 11, 2024), the Company is providing this [...]

Universal Ibogaine provides Bi-weekly Default Status Report on year-end filings and update on pending sale of Belize property

2024-12-19T12:28:48-08:00December 11th, 2024|Universal Ibogaine News|

Calgary, AB – TheNewswire - December 11, 2024 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, provides the following bi-weekly default status report update: Management Cease Trade Order (“MCTO”) Further to the Company’s prior news releases (November 18 and November 26, 2024), the Company is providing this bi-weekly default status report (the “Default [...]

Universal Ibogaine advises of Offer to purchase Belize property and update on application for Management Cease Trade Order

2024-12-19T12:23:35-08:00November 26th, 2024|Universal Ibogaine News|

Calgary, AB – TheNewswire - November 26, 2024 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, is pleased to advise that it has received an offer to purchase (the “Offer”) its undeveloped 20-acre island property in Belize (the “Property”) for USD 300,000. The Offer is to [...]

Universal Ibogaine Advises of Application for Management Cease Trade Order

2024-12-19T12:17:55-08:00November 18th, 2024|Universal Ibogaine News|

Calgary, AB – November 18, 2024 – TheNewswire – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it has made an application to the Alberta Securities Commission (as Principal Regulator) and the British Columbia Securities Commission, to approve a temporary management case trade order (“MCTO”) under National [...]

Universal Ibogaine to Issue Common Shares Pursuant to Debt Settlement

2024-06-18T20:54:30-07:00June 17th, 2024|Universal Ibogaine News|

Calgary, AB – June 17, 2024 – TheNewswire – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, advises that it has reached an agreement to issue a total of 4,040,067 common shares at a price of $0.015 per share pursuant to a settlement of accounts payable of [...]

Universal Ibogaine Announces Closing of Private Placement Financing

2024-06-18T20:55:08-07:00June 7th, 2024|Universal Ibogaine News|

Calgary, AB – TheNewswire - June 7, 2024 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, advises that it has closed its previously announced (see News Release of April 12) non-brokered private placement offering of common shares (the “Offering”) and has issued a total of 13,500,000 [...]

Go to Top